Romark established its operation in Puerto Rico in 2019. #NewsismyBusiness
Research-based pharmaceutical company Romark Global Pharma has completed a clinical trial that showed that a tablet it is manufacturing at its Manatí plant can prevent about 80% of hospitalizations caused by COVID-19 in high-risk patients, company CEO Marc Ayers confirmed. “We submitted data to the Food and Drug Administration in April and we’re now waiting […]
Romark, a research-based pharmaceutical company focused on the discovery, development and delivery of innovative new medicines, primarily in the field of infectious diseases, announced that the U.S. Food and Drug Administration has given its approval to the production of ALINIA, at its Manatí plant. The $80 million, state-of-the-art facility opened a little more than a […]
Romark Global Pharma, a global biopharmaceutical dedicated to the discovery and development of new drugs to treat infectious diseases and cancer, officially opened its new $80 million manufacturing plant in Manatí. Flanked by Gov. Rosselló administration officials, Romark CEO Marc Ayers said, “with this expansion Romark will manufacture its products Alinia and NT-300, a new […]
A Dow Jones/Factiva content provider since 2014
Subscribe to our Dollars & Sense podcast!
NIMB ON SOCIAL MEDIA